Marvin Hausman

Marvin Hausman

Fortune : 397 609 $ au 31/08/2026

84 ans
Health Technology
Commercial Services
Consumer Services

Profil

Dr. Marvin S.
Hausman
, MD, is a Chairman & Chief Executive Officer at Total Nutraceutical Solutions, Inc., a President at Northwest Medical Research Partners, Inc., a Chief Scientific Officer at Ludwig Enterprises, Inc., a Chairman at SwabAi Diagnostics, Inc., a Chief Scientific Officer at Xycota Biosciences LLC and an Independent Director at NuGenerex Immuno-Oncology, Inc. He is on the Board of Directors at NuGenerex Immuno-Oncology, Inc. Dr. Hausman was previously employed as a Chief Scientific Officer by Lion Biotechnologies, Inc., a Chairman, Chief Science & Technology Officer by Entia Biosciences, Inc., a Chairman, President & Chief Executive Officer by OXIS International, Inc., a Chairman, President & Chief Executive Officer by Axonyx, Inc., a Member-Governors Board by New York University, a Member by American Association for the Advancement of Science, a Member by American Board of Urology, a Member by American College of Surgeons, a Member by American Federation for Medical Research, a Member by American Medical Association, a Member by American Urological Association Education & Research, Inc., a Member by Association for Academic Surgery, a Member by California Medical Association, a Co-Founder by King Pharmaceuticals Research & Development, Inc., a Research Associate by National Institutes of Health, a Member by New York Academy of Sciences, a Member by The American Association of Immunologists, a Member by The Royal Society of Medicine, and a Chairman & Chief Executive Officer by W World Corp.
He also served on the board at Arbios Technologies, Inc., OXIS International, Inc., Regent Assisted Living, Inc., TorreyPines Therapeutics, Inc. and Arbios Systems, Inc. He received his undergraduate degree from Brooklyn College and a doctorate degree from New York University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
29/04/2026 37 758 000 ( 22,59 % ) 377 580 $ 31/08/2026
16/06/2025 2 000 000 ( 28,57 % ) 20 000 $ 31/08/2026
08/05/2017 14 625 ( 9,72 % ) 29 $ 31/12/2021

Postes actifs de Marvin Hausman

SociétésPosteDébut
NUGENEREX IMMUNO-ONCOLOGY, INC. Directeur/Membre du Conseil -
LUDWIG ENTERPRISES, INC. Fondateur 11/02/1988
Président -
Directeur Général 01/10/2008
Northwest Medical Research Partners, Inc.
Fondateur 01/10/1995

Anciens postes connus de Marvin Hausman

SociétésPosteFin
IOVANCE BIOTHERAPEUTICS, INC. Directeur Technique/Scientifique/R&D 26/09/2013
GT BIOPHARMA, INC. Directeur Financier/CFO -
Directeur/Membre du Conseil 23/05/2007
Directeur Général 06/10/2006
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Marvin Hausman

Formation de Marvin Hausman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

84

Relations au 1er degré

30

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées30

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Government

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Northwest Medical Research Partners, Inc.

Commercial Services

Finance

Commercial Services

Association for Academic Surgery

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Marvin Hausman
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇